Underdosing of predominantly alpha-adrenocpt agonists, subs

This code signifies that a patient is experiencing the adverse effects of receiving an insufficient amount of a predominantly alpha-adrenoreceptor agonist. This typically involves medications like phenylephrine or midodrine, which are used to constrict blood vessels or raise blood pressure. The underdosing leads to a failure to achieve the desired therapeutic effect or a worsening of the condition the medication was intended to treat.

Apply this code when documentation indicates a patient is not receiving enough of an alpha-agonist medication, and this is impacting their clinical status during a follow-up visit. Examples include a patient with orthostatic hypotension whose blood pressure remains low due to an inadequate dose of midodrine, or a patient with nasal congestion whose symptoms persist because of insufficient phenylephrine. This code is specifically for subsequent encounters where the underdosing is being managed or evaluated.

• Ensure documentation clearly states "underdosing" and specifies the medication as a predominantly alpha-adrenoreceptor agonist.
• Confirm the encounter type is "subsequent" (D) as opposed to initial or sequela.
• Always code the specific manifestation of the underdosing (e.g., hypotension, persistent congestion) as a primary diagnosis, with this code as a secondary diagnosis.